Foresite Capital Management II’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Foresite Capital Management II’s Portfolio BLCM Stock Details BLCM Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell
2017 Q2	$591K	Sell
2017 Q1	$1.3M	Buy
2015 Q1	–	Sell
2014 Q4	$2.42M	Buy